Transgenic mice have been developed that express exclusively human sickle cell b hemoglobi n and have major pathological features found in humans with sickle cell disease. These mice provide a unique opportunit y to investigate the fundamenta l mechanisms of this disease and to design new strategies to correct the associated genetic defect(s). We found that in breeding males expressing only adult human a -globin and sickle b -globin (homozygou s SS mice) with females containing these transgenes plus one copy of the mouse b -globin gene (hemizygous SS mice) greater than expected numbers of hemizygou s offspring were produced than homozygou s mice (carrying no mouse b -globin gene). These hemizygou s mice, expressing the human a and sickle b s transgenes in combination with mouse b / , were used for our preliminary studies of their renal pathology. No kidney lesions were found in the control (129/Sv) mice, whereas about 50% of the hemizygou s SS mice showed mild-to-severe kidney lesions, including glomerulonephritis , cystic atypical hyperplastic tubules, and general nephropath y. Kidneys of some hemizygou s mice were normal or showed minimal nephropath y, yet those of the susceptible phenotyp e developed a mild-to-more-sever e form of renal lesions. The tubular epithelium of kidneys of hemizygous mice of the more affected phenotype exhibited increased expression of inducible nitric oxide synthase with an increased 3-nitrotyrosine in close proximity. There was also a stronger immunostaining for vascular cell adhesion molecule-1 in the interstitial capillary cells as well as the tubular epithelial cells of the renal cortex, compared with normal control mice. The occurrence of a high incidence of renal abnormalities in our hemizygou s SS mice suggests that these mice may provide a suitable model to study the pathogenesi s of nephropath y resulting from altered blood ow and/or insuf cient oxygen delivery.
INTRODUCTION
Sickle cell disease (SCD) is a vascular disease caused by a mutant b -globin hemoglobinopathy. SCD is associated with a large spectrum of pathologic complications caused by the aggregation and polymerization of the abnormal b sickle hemoglobin (HbS) within the red blood cell (7) . The resulting deformation of the cell's outer membrane impairs its ability to pass through capillaries and other small vascular channels; congestion of the vascular beds results, followed by tissue ischemia and infarction in bone, lungs, brain, liver, spleen, and kidney. This ischemia is responsible for the earliest clinical manifestation of SCD, the acute pain crisis resulting from bone marrow infarction. Genotype affects the course of disease; populations in Bedouin Arabs and tribes from central India who naturally have a high hemoglobin F level exhibit mild disease (7) ; persons with sickle cell trait (one b s gene, one normal b gene) are mostly asymptomatic, although occasional hematuria and isosthenuria (reduction in urine concentrating ability) are observed (12) ; individuals heterozygous for the variant b s-Antilles exhibit a higher propensity for b s-Antilles to polymerize when deoxygenated (19) .
Clinical and experimental results indicate that nitric oxide (NO) can have opposing roles in sickle cell disease. The plasma from human SCD patients in crisis strongly induces nitric oxide synthase in endothelial cells (eNOS, 13) . NO from endothelial cells regulates basal renal vascular tone and endothelial function. It has been argued that SCD patients also exhibit clinical signs of excessive NO release, such as elevated levels of plasma nitrite during steady state (26) , low blood pressure (15) , a signi cantly reduced frequency of renal hypertension (15, 28) , and priapism (2, 11) . However, recent clinical data suggest that patients with SCD also suffer from impairment of endothelial production of NO. In fact, several investigators have now reported that plasma levels of nitric oxide metabolites (Nox) and L-arginine (the substrate for the NO synthase enzymes) are depressed in patients with SCD, particularly during vaso-occlusive crisis and the acute chest syndrome, and that these levels vary inversely with pain symptomology (18, 20) . These data suggest that dysfunctional vascular endothelium may contribute to the clinical events suffered by patients with SCD. Reduced Nox (nitrate and nitrite) levels are consistent with reduced endothelial NO generation with subsequent reductions in the nitrate and nitrite metabolites of NO reactions with hemoglobin and oxygen. Further evidence for endothelial dysfunction is provided by increased levels of soluble VCAM-1 in patients with SCD, a vascular cell adhesion molecule whose synthesis is normally inhibited by NO (8) . Setty and Stuart (30) and Stuart and Setty (33) have shown that hypoxia and oleic acid treatment enhances erythrocyte-endothelial cell adhesion, and that this interaction was mediated by binding of VCAM-1 on endothelial cells. Further, Stuart and Setty (33) also reported that levels of soluble VCAM-1 are elevated in the plasma of patients with vaso-occlusive crisis and the acute chest syndrome, and these elevations are inversely related to the levels of plasma No x . These results suggest that increased expression of VCAM-1 by hypoxia and other factors in the setting of the reduced NO production observed in patients with SCD, contribute to systemic and pulmonary erythrocyte sequestration. Supplementing NO-based therapies may ameliorate these events.
Renal failure in patients with SCD is associated with loin pain, hematourea, focal interstitial nephritis, tubular dysfunction, nephrotic syndrome, and papillary necrosis (24) . Proteinurea due to hyper ltration and glomerulopathy occurs frquently in SCD patients (3, 36) . The prevalence of microhematourea (blood in the urine) is similar in persons with SCD and those with sickle cell trait. Similarly, both SCD and sickle cell trait patients can present with renal papillary necrosis resulting from medullary ischemia and infarction (36) . Signi cant proximal tubular dysfunction is not a common feature in SCD or sickle cell trait patients (29) .
Despite the impressive progress in our knowledge of sickle cell anemia, many aspects of sickle cell disease remain poorly understood and thus limit our treatment options. We are studying the potential roles of the production and response to NO in the pathophysiolog y and the therapy of human SCD by using a transgenic mouse model of the disease. The development of this sickle cell mouse model involved crossing transgenic mice expressing transgenes for human a -and bglobin genes onto a background of a -thalassemic (ma / ) and b -thalassemic (mb / ) mice (22, 27) . Following successive crosses, lines of mice that express predominately human HbS (ha b s ) and no mouse globin genes (ma / mb / ) were produced. These transgenic mice have major pathological features related to those found in humans with SCD, thus providing us a unique opportunity to investigate the fundamental mechanism(s) of this disease and design new strategies to treat and to correct the genetic defect(s) associated with it.
Our breeding of mice was carried out using homozygous males (ha b s ; ma / mb / ) mice crossed with female mice containing the human a -globin and sickle b -globin transgenes, no mouse a -globin genes, and hemizygous for deletion of the mouse b -globin genes (ha b s ; ma / mb / , hemizygous mice) (22) . Sickle cell (SS) homozygous mice (particularly male mice) born from such matings were found to be fragile and few survived to the adult stage. As such breeding produced greater numbers of mice hemizygous for the mouse b -globin gene and no mouse a -globin gene (hemizygous mice), these were used for initial studies of tissue pathology.
Overt renal failure is associated with 40% of the deaths of SCD patients (25) . Because sickle trait individuals carrying only one copy of the b s gene still exhibit a number of renal de ciencies, including defective urine concentrating ability and sickle cell nephropathy (28) , the kidneys of hemizygous mice were carefully examined. Because of the critical roles played by the inducible nitric oxide synthase and the cell adhesion molecules in sickle cell disease we studied the renal expression of these proteins using immunohistochemistry. We also examined the kidneys for 3-nitrotyrosine, a marker for peroxynitrite nitration of proteins.
METHODS

Mice-Breeding and Husbandry:
Sickle cell mice to found our colony were obtained from Drs. Mohandas Narla and Chris Paszty of Lawrence Berkeley Laboratories (22) . We have subsequently established a speci c pathogen-free colony at the NCI at Frederick via in vitro embryo rederivation. Homozygous male mice were bred routinely with hemizygous females and their offspring were sexed and genotyped at 3 to 4 weeks of age. Animals were kept 4-5 per hanging polycarbonate cage with hardwood chip bedding and were provided food (NIH-31 Block open formula 6% Modi ed: Zeigler Brothers, Gardners, PA) and water (acidied tap) ad libitum. The lighting schedule was 12 hours on and 12 hours off. Environmental temperatures were held between 68 and 72 F, with a relative humidity of 50 5%. Animals were cared for and studied humanely according to the US Public Health Service Policy on the Care and Use of Animals, and the Guide for the Care and Use of Laboratory Animals. The animal facility was accredited by the Association for the Assessment of Laboratory Animal Care International.
Hemizygous SS mice of various age groups were used for the present study. The control male mice of the same age groups used in this study were of the 129/SvImJ strain purchased from Jackson Laboratories (Bar Harbor, ME, USA).
Necropsy: Groups of hemizygous sickle cell mice and control mice of different age groups, ie, 3 to 4 weeks (6 hemizygous and 6 control males), 8 weeks (8 hemizygous SS and 9 control males), 5 months (13 hemizygous SS and 6 control males), and 7-8 months (15 hemizygous SS females, 5 hemizygous SS, and 9 control males) of age, were carefully necropsied. The kidneys were weighed and xed in 10% neutral buffered formalin, embedded in paraf n, sectioned at 5 l m, and stained with hematoxylin and eosin for histological examinations.
Immunohistochemistry: Kidney sections were evaluated for the immunohistochemical localization and immunoreactive intensity of inducible nitric oxide synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1). Because NO release in the presence of an oxidative environment is associated with peroxynitrite formation that nitrosates tyrosine residues, we also examined the kidneys for 3-nitrotyrosine. Brie y, after deparaf nization the sections were microwaved for 10 minutes in citrate buffer for antigen retrieval. Polyclonal rabbit anti-iNOS antibody (Santa Cruz Biotechnology, Santa Cruz, CA), polyclonal rabbit anti-3-nitrotyrosine antibody (Upstate Biotechnology, Lake Placid, NY) and monoclonal anti-VCAM-1 antibody (Endogen, Boston, MA) were used at dilutions of 1:1,000, 1:1,500, and 1:4,000, respectively. Reactions were visualized with an avidin-biotinperoxidase kit (Vectastain Elite Kit; Vector Laboratories, Burlingame, CA) with diaminobenzidine as the chromagen and hematoxylin as the nuclear counterstain. To demonstrate the speci city of the immunostaining, primary antibodies were omitted from each staining series. The staining reaction in kidney tissues were scored for intensity and extent of staining. The staining intensity of the cells was categorized as negative ( ), weak ( ), moderate ( ), or strong ( ), whereas the extent of staining was scored as 1 if fewer than 25% of cells were positive, 2 if 25-75% of cells were positive, and 3 if more than 75% of cells were positive. TOXICOLOGIC PATHOLOGY Hemizygous  8  SS mice  None  6  3  5  4  Minimal  3  2  2  2  Mild  0  2 
RESULTS
Kidneys of some hemizygous SS mice were normal or showed minimal nephropathy yet those of susceptible phenotype had a mild-to-more severe form, of nephropathy. There was a 50% to 75% average increase in the weights of the kidneys in some hemizygous SS mice, as compared to those of control mice, observed at different time points ( Figure 1 ). The major types of kidney lesions found in affected mice were glomerulonephritis, dilated tubules, and atypical tubules. Other types of renal lesions such as tubular degeneration, mild necrosis, and interstitial brosis were included under nephropathy. All lesions were classi ed as minimal, mild, moderate, or severe, as shown in Tables 1-3 .
No kidney lesions were found in the control mice or neonatal hemizygous SS mice, yet roughly 50% of the hemizygous mice, 8 weeks or older, showed mild to severe kidney lesions. Interestingly, these lesions were primarily restricted to the renal cortex. These cortical lesions exhibited mild nephropathy and multiple cysts, some of which were lined by hyperplastic tubular epithelial cells (Figure 2A, B) . The severity of these lesions increased with age (Tables 1,  2 , 3), and at 7 to 8 months of age several animals had enlarged kidneys showing numerous cortical dilated tubules ( Figure 3A ). Most of these dilated tubules were lined by multiple layers of atypical cells that resembled the preneoplastic dysplastic lesions known to occur in mice exposed to renal carcinogens (14) (Figure 3B , C). Some of these atypical hyperplastic tubules coalesced to produce larger lesions giving the appearance of early neoplastic changes ( Figure 3D ). Many affected kidneys of hemizygous animals showed glomerulonephritis with a thickened glomerular basement membrane. We assume that basement membrane dense deposits are autoantigen-antibody complexes (Figure 4) .
The tubular epithelium of kidneys of hemizygous mice of the susceptible phenotype exhibited an increased expression of iNOS ( Figure 5B ) and 3-nitrotyrosine ( Figure 5D ), compared with normal control mice (Tables 4 and 5 ). Both iNOS and 3-nitrotyrosine were localized mainly in the epithelial cells lining the abnormal (dilated or atypical) tubules. The immunostaining was mostly cytoplasmic for iNOS but was both cytoplasmic and nuclear for 3-nitrotyrosine. The observations suggest that iNOS and NO-reactive end-products such as peroxynitrite are being produced in the kidney of hemizygous sickle cell mice. These reactions appear to generate nitration of tyrosine residues of some renal proteins as early as 8 weeks of age. Stronger immunostaining for VCAM-1 was also observed in interstitial capillary cells as well as epithelial cells lining the tubules in kidneys as compared to the controls (Figure 5F, Tables 4 and 5) . The VCAM-1 staining was exclusively cytoplasmic. The differences in the intensity and extent of immunostaining for iNOS, 3-nitrotyrosine, and VCAM-1 between the kidneys of hemizygous and control mice were more remarkable in the younger mice as compared to the older mice (8 weeks vs 7-8 months, compare the data in Table 4 with Table 5 ). 
DISCUSSION
Earlier reports (10, 22, 27) have described the moderate to severe renal abnormalities found in the homozygous SS mice. Histologic analysis of sickle cell mouse kidneys revealed brosis, cysts, infarcts, multifocal proximal SS  Moderate  3  3  3  SS  Severe  3  3  3  SS  Severe  3  3  3  SS  Moderate  3  3  3  SS  Moderate  3  2  3  SS  Minimal  2  2  2  129  No lesions  2  2  2  129  No lesions  2  2  2  129  No lesions  2  2  3  129  No lesions  2 tubular injury resulting in tubular dilation, and glomerulopathy, including basement membrane thickening and iron deposition. We show here for the rst time that the hemizygous SS mice also exhibit kidney lesions that are unrelated to the renal disease found in the homozygous animals. Whereas kidney lesions were absent in the 129/SvImJ control mice, nearly half of the hemizygous SS mice showed agedependent kidney lesions, which included glomerulonephritis, dilated or atypical hyperplastic tubules, and general nephropathy.
Humans with SCD (Hb SS) or sickle cell trait (Hb AS) present several types of kidney abnormalities, including glomerulonephritis, glomerular hypertrophy, focal glomerulosclerosis, papillary necrosis, and occasional malignant medullary carcinomas (24, 28, 35) . Although glomerulonephritis is commonly seen in hemizygous SS mice, the lesions are mostly restricted to the renal cortex and are rarely seen in the medullary or papillary region of the kidney, which is more characteristic of the human sickle cell disease and trait. Thus, the hemizygous sickle cell mice may not be a suitable model for human sickle cell trait. None the less, one of the target organs in both cases is the kidney, and the root cause of the pathology in both is likely to be the disruption of the renal microvasculature by sickled cells and a resulting ischemia/reperfusion injury.
Clinical studies have shown evidence of an increased synthesis of NO in patients with SCD, including elevated plasma nitrite (26) , low blood pressure (15) , reduced incidence of renal hypertension (28) , and priapism (2, 11) . An increased expression under ambient conditions of hepatic iNOS has been reported in the a H b S [b MDD ] (indicating they had a double deletion of the mouse b major -globin genes) transgenic sickle cell mouse model (21) . Using this model, Bank et al demonstrated an increased renal expression of both iNOS, eNOS, and nitrotyrosine by Western blot and immunohistochemistry, and that the resulting ONOO (peroxynitrite) was responsible for both the renal cell damage and apoptosis (4) (5) (6) . In the present study, the renal tubular epithelium in our hemizygous SS mice of the more susceptible phenotype likewise exhibited increased expression of iNOS and nitrotyrosine in close proximity. Whether NO/ONOO plays a similar role in mediating the renal tubular cell damage through apoptosis in our hemizygous sickle cell mice remains to be investigated.
Paradoxically, patients with SCD, although sometimes showing signs of high levels of NO production (26) , have been reported to also exhibit increased levels of VCAM-1 and other adhesion proteins (9, 30, 33) . Our nding that the epithelial cells lining the renal interstitial capillaries and cortical tubules in the hemizygous mice also simultaneously showed an increased expression of VCAM-1 and NO/ONOO is therefore somewhat intriguing because NO has been shown by several investigators to down-regulate endothelial and leukocyte adhesion molecule expression (17, 23, 31, 32, 34) . A similar co-elevation of iNOS, VCAM-1, intercellular cell adhesion molecule-1 (ICAM-1), and endothelial selectin (E-selectin) cell adhesion molecules is known to occur in another chronic vascular occlusion disease, that of systemic sclerosis (1) . In addition, Kawachi et al (16) have reported that in (iNOS / ) mice, iNOS downregulated VCAM-1 expression in the acute state of gut in ammation but no longer did so under chronic in ammation (chronic colitis) in SCID mice. Therefore, it is not unexpected that in our hemizygous SS mice with chronic kidney disease that we could see independent overexpression of both iNOS and VCAM-1 in the cortical tubular epithelial cells. However, increased iNOS expression may be a compensatory protective response to anemia, high cardiac output and chronic ischemia-reperfusion injury. Concurrent VCAM-1 expression may simply re ect endothelial injury from such events.
In summary, we have found that about 50% of the hemizygous SS mice showed mild-to-severe renal pathology. The reason for the higher incidence of renal abnormalities in these mice is not yet known. Because some of these kidney lesions appear to be more severe than those described for homozygous mice (10, 22, 27) , the renal pathology in hemizygous mice may not be exclusively related to changes in the kinetics of hemoglobin S polymerization. Studies are in progress to determine other possible factors that could account for the abnormal kidney pathology in the hemizygous sickle cell mice. In any case, a high incidence of such renal abnormalities in our hemizygous SS mice suggests that these mice may provide a suitable model to study certain aspects of the pathogenesis of nephropathy resulting from altered oxygen delivery and possible tissue ischemia, and to assess proposed therapies.
